News Related to Systemic Sclerosis

Related coverage linked through entity extraction aliases.

AbbVie Advances Immunology Pipeline with Skyrizi, Rinvoq, and Lutikizumab Data Expected in 2026

Mar 18, 2026

AbbVie reported positive Phase 3 data for Skyrizi's subcutaneous Crohn's disease treatment and is advancing lutikizumab and Rinvoq in hidradenitis suppurativa, with multiple readouts expected throughout 2026 as the company pursues combination therapy strategies.

CAR-T Therapy Preserves Fertility in Lupus; Bispecific Antibodies Show Promise in Autoimmune Diseases

Feb 24, 2026

A 24-year-old woman with refractory lupus achieved two successful pregnancies following dual-target CAR-T cell therapy, while bispecific T cell engagers showed efficacy in treatment-refractory antisynthetase syndrome and systemic sclerosis patients.